Skip to main content

Merck KGaA lifts outlook, revamp costs hit results

Pharmaceutical and chemical company Merck KGaA says second-quarter earnings took a hit from €394 million in one-time impairments, but lifted its outlook for full-year earnings and revenue on expected impetus from emerging markets.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.